Mammary tumorigenesis induced by fibroblast growth factor receptor 1 requires activation of the epidermal growth factor receptor

Journal of Cell Science

Volumn 124, Issue 18, 2011, Pages 3106-3117

  Bade, Lindsey K ^a   Goldberg, Jodi E ^b   DeHut, Hazel A ^c   Hall, Majken K ^c   Schwertfeger, Kathryn L ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b HAMLINE UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Breast cancer; EGFR; FGFR1; Mammary tumor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; FIBROBLAST GROWTH FACTOR RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST EPITHELIUM; BREAST TUMOR; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; EPIDERMAL GROWTH FACTOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MAMMARY GLANDS, HUMAN; MAP KINASE SIGNALING SYSTEM; MICE; MICE, TRANSGENIC; QUINAZOLINES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1;

MOUSE MAMMARY TUMOR VIRUS; MUS MUSCULUS;

EID: 80054023029     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.082651     Document Type: Article

References (71)

1. Alroy, I. and Yarden, Y. (1997). The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions. FEBS Lett. 410, 83-86.
2. Andre, F., Job, B., Dessen, P., Tordai, A., Michiels, S., Liedtke, C., Richon, C., Yan, K., Wang, B., Vassal, G. et al. (2009). Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array. Clin. Cancer Res. 15, 441-451.
3. Bieche, I., Lerebours, F., Tozlu, S., Espie, M., Marty, M. and Lidereau, R. (2004). Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature. Clin. Cancer Res. 10, 6789-6795.
4. Brandt, R., Eisenbrandt, R., Leenders, F., Zschiesche, W., Binas, B., Juergensen, C. and Theuring, F. (2000). Mammary gland specific hEGF receptor transgene expression induces neoplasia and inhibits differentiation. Oncogene 19, 2129-2137.
5. Brown, C. L., Meise, K. S., Plowman, G. D., Coffey, R. J. and Dempsey, P. J. (1998). Cell surface ectodomain cleavage of human amphiregulin precursor is sensitive to a metalloprotease inhibitor. Release of a predominant N-glycosylated 43-kDa soluble form. J. Biol. Chem. 273, 17258-17268.
6. Chin, K., DeVries, S., Fridlyand, J., Spellman, P. T., Roydasgupta, R., Kuo, W. L., Lapuk, A., Neve, R. M., Qian, Z., Ryder, T. et al. (2006). Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10, 529-541.
7. Cho, E. Y., Choi, Y. L., Han, J. J., Kim, K. M. and Oh, Y. L. (2008). Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization. Pathol. Int. 58, 17-25.
8. Ciarloni, L., Mallepell, S. and Brisken, C. (2007). Amphiregulin is an essential mediator of estrogen receptor alpha function in mammary gland development. Proc. Natl. Acad. Sci. USA 104, 5455-5460.
9. Dailey, L., Ambrosetti, D., Mansukhani, A. and Basilico, C. (2005). Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev. 16, 233-247.
10. Dickson, C., Spencer-Dene, B., Dillon, C. and Fantl, V. (2000). Tyrosine kinase signalling in breast cancer: fibroblast growth factors and their receptors. Breast Cancer Res. 2, 191-196.
11. Elbauomy Elsheikh, S., Green, A. R., Lambros, M. B., Turner, N. C., Grainge, M. J., Powe, D., Ellis, I.O. and Reis-Filho, J. S. (2007). FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis. Breast Cancer Res. 9, R23.
12. Eltarhouny, S. A., Elsawy, W. H., Radpour, R., Hahn, S., Holzgreve, W. and Zhong, X. Y. (2008). Genes controlling spread of breast cancer to lung "gang of 4". Exp. Oncol. 30, 91-95.
13. Eswarakumar, V. P., Lax, I. and Schlessinger, J. (2005). Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 16, 139-149.
14. Fabian, C. J., Zalles, C., Kamel, S., Kimler, B. F., McKittrick, R., Tranin, A. S., Zeiger, S., Moore, W. P., Hassanein, R. S., Simon, C. et al. (1994). Prevalence of aneuploidy, overexpressed ER, and overexpressed EGFR in random breast aspirates of women at high and low risk for breast cancer. Breast Cancer Res. Treat. 30, 263-274.
15. Fox, S. B., Smith, K., Hollyer, J., Greenall, M., Hastrich, D. and Harris, A. L. (1994). The epidermal growth factor receptor as a prognostic marker: results of 370 patients and review of 3009 patients. Breast Cancer Res. Treat. 29, 41-49.
16. Gelsi-Boyer, V., Orsetti, B., Cervera, N., Finetti, P., Sircoulomb, F., Rouge, C., Lasorsa, L., Letessier, A., Ginestier, C., Monville, F. et al. (2005). Comprehensive profiling of 8p11-12 amplification in breast cancer. Mol. Cancer Res. 3, 655-667.
17. Gridelli, C., Maione, P., Bareschino, M. A., Schettino, C., Sacco, P. C., Ambrosio, R., Barbato, V., Falanga, M. and Rossi, A. (2010). Erlotinib in the treatment of nonsmall cell lung cancer: current status and future developments. Anticancer Res. 30, 1301-1310.
18. Grimm, S. L. and Rosen, J. M. (2003). The role of C/EBPbeta in mammary gland development and breast cancer. J. Mammary Gland Biol. Neoplasia 8, 191-204.
19. Grose, R. and Dickson, C. (2005). Fibroblast growth factor signaling in tumorigenesis. Cytokine Growth Factor Rev. 16, 179-186.
20. Gupta, G. P., Nguyen, D. X., Chiang, A. C., Bos, P. D., Kim, J. Y., Nadal, C., Gomis, R. R., Manova-Todorova, K. and Massague, J. (2007). Mediators of vascular remodelling co-opted for sequential steps in lung metastasis. Nature 446, 765-770.
21. Kenney, N. J., Smith, G. H., Maroulakou, I. G., Green, J. H., Muller, W. J., Callahan, R., Salomon, D. S. and Dickson, R. B. (1996a). Detection of amphiregulin and Cripto-1 in mammary tumors from transgenic mice. Mol. Carcinog. 15, 44-56.
22. Kenney, N. J., Smith, G. H., Rosenberg, K., Cutler, M. L. and Dickson, R. B. (1996b). Induction of ductal morphogenesis and lobular hyperplasia by amphiregulin in the mouse mammary gland. Cell Growth Differ. 7, 1769-1781.
23. Klijn, J. G., Berns, P. M., Schmitz, P. I. and Foekens, J. A. (1992). The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocr. Rev. 13, 3-17.
24. Komurasaki, T., Toyoda, H., Uchida, D. and Morimoto, S. (1997). Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4. Oncogene 15, 2841-2848.
25. Komurasaki, T., Toyoda, H., Uchida, D. and Nemoto, N. (2002). Mechanism of growth promoting activity of epiregulin in primary cultures of rat hepatocytes. Growth Factors 20, 61-69.
26. Kondapaka, S. B., Fridman, R. and Reddy, K. B. (1997). Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells. Int. J. Cancer 70, 722-726.
27. Koziczak, M., Holbro, T. and Hynes, N. E. (2004). Blocking of FGFR signaling inhibits breast cancer cell proliferation through downregulation of D-type cyclins. Oncogene 23, 3501-3508.
28. Kwek, S. S., Roy, R., Zhou, H., Climent, J., Martinez-Climent, J. A., Fridlyand, J. and Albertson, D. G. (2009). Co-amplified genes at 8p12 and 11q13 in breast tumors cooperate with two major pathways in oncogenesis. Oncogene 28, 1892-1903.
29. LeJeune, S., Leek, R., Horak, E., Plowman, G., Greenall, M. and Harris, A. L. (1993). Amphiregulin, epidermal growth factor receptor, and estrogen receptor expression in human primary breast cancer. Cancer Res. 53, 3597-3602.
30. Letessier, A., Sircoulomb, F., Ginestier, C., Cervera, N., Monville, F., Gelsi-Boyer, V., Esterni, B., Geneix, J., Finetti, P., Zemmour, C. et al. (2006). Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers. BMC Cancer 6, 245.
31. Liu, J. F., Crepin, M., Liu, J. M., Barritault, D. and Ledoux, D. (2002). FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. Biochem. Biophys. Res. Commun. 293, 1174-1182.
32. Livak, K. J. and Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402-408.
33. Luetteke, N. C., Qiu, T. H., Fenton, S. E., Troyer, K. L., Riedel, R. F., Chang, A. and Lee, D. C. (1999). Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 126, 2739-2750.
34. Ma, L., Gauville, C., Berthois, Y., Millot, G., Johnson, G. R. and Calvo, F. (1999). Antisense expression for amphiregulin suppresses tumorigenicity of a transformed human breast epithelial cell line. Oncogene 18, 6513-6520.
35. Ma, L., de Roquancourt, A., Bertheau, P., Chevret, S., Millot, G., Sastre-Garau, X., Espie, M., Marty, M., Janin, A. and Calvo, F. (2001). Expression of amphiregulin and epidermal growth factor receptor in human breast cancer: analysis of autocriny and stromal-epithelial interactions. J. Pathol. 194, 413-419.
36. Mitsudomi, T. and Yatabe, Y. (2010). Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer. FEBS J. 277, 301-308.
37. Moscatello, D. K., Holgado-Madruga, M., Godwin, A. K., Ramirez, G., Gunn, G., Zoltick, P. W., Biegel, J. A., Hayes, R. L. and Wong, A. J. (1995). Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors. Cancer Res. 55, 5536-5539.
38. Ornitz, D. M. (2000). FGFs, heparan sulfate and FGFRs: complex interactions essential for development. BioEssays 22, 108-112.
39. Panico, L., D'Antonio, A., Salvatore, G., Mezza, E., Tortora, G., De Laurentiis, M., De Placido, S., Giordano, T., Merino, M., Salomon, D. S. et al. (1996). Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissues. Int. J. Cancer 65, 51-56.
40. Penault-Llorca, F., Bertucci, F., Adelaide, J., Parc, P., Coulier, F., Jacquemier, J., Birnbaum, D. and deLapeyriere, O. (1995). Expression of FGF and FGF receptor genes in human breast cancer. Int. J. Cancer 61, 170-176.
41. Plowman, G. D., Green, J. M., McDonald, V. L., Neubauer, M. G., Disteche, C. M., Todaro, G. J. and Shoyab, M. (1990). The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity. Mol. Cell. Biol. 10, 1969-1981.
42. Pond, A. C., Herschkowitz, J. I., Schwertfeger, K. L., Welm, B., Zhang, Y., York, B., Cardiff, R. D., Hilsenbeck, S., Perou, C. M., Creighton, C. J. et al. (2010). Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancer. Cancer Res. 70, 4868-4879.
43. Presta, M., Dell'Era, P., Mitola, S., Moroni, E., Ronca, R. and Rusnati, M. (2005). Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev. 16, 159-178.
44. Qi, C. F., Liscia, D. S., Normanno, N., Merlo, G., Johnson, G. R., Gullick, W. J., Ciardiello, F., Saeki, T., Brandt, R., Kim, N. et al. (1994). Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas. Br. J. Cancer 69, 903-910.
45. Reed, J. R., Leon, R. P., Hall, M. K. and Schwertfeger, K. L. (2009). Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis. Breast Cancer Res. 11, R21.
46. Rimawi, M. F., Shetty, P. B., Weiss, H. L., Schiff, R., Osborne, C. K., Chamness, G. C. and Elledge, R. M. (2010). Epidermal growth factor receptor expression in breast cancer association with biologic phenotype and clinical outcomes. Cancer 116, 1234-1242.
47. Sahin, U., Weskamp, G., Kelly, K., Zhou, H. M., Higashiyama, S., Peschon, J., Hartmann, D., Saftig, P. and Blobel, C. P. (2004). Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell Biol. 164, 769-779.
48. Schneider, M. R. and Wolf, E. (2009). The epidermal growth factor receptor ligands at a glance. J. Cell. Physiol. 218, 460-466.
49. Schwertfeger, K. L., Xian, W., Kaplan, A. M., Burnett, S. H., Cohen, D. A. and Rosen, J. M. (2006). A critical role for the inflammatory response in a mouse model of preneoplastic progression. Cancer Res. 66, 5676-5685.
50. Shelly, M., Pinkas-Kramarski, R., Guarino, B. C., Waterman, H., Wang, L. M., Lyass, L., Alimandi, M., Kuo, A., Bacus, S. S., Pierce, J. H. et al. (1998). Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes. J. Biol. Chem. 273, 10496-10505.
51. Shirakata, Y., Komurasaki, T., Toyoda, H., Hanakawa, Y., Yamasaki, K., Tokumaru, S., Sayama, K. and Hashimoto, K. (2000). Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes. J. Biol. Chem. 275, 5748-5753.
52. Shoyab, M., Plowman, G. D., McDonald, V. L., Bradley, J. G. and Todaro, G. J. (1989). Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science 243, 1074-1076.
53. Silvy, M., Giusti, C., Martin, P. M. and Berthois, Y. (2001). Differential regulation of cell proliferation and protease secretion by epidermal growth factor and amphiregulin in tumoral versus normal breast epithelial cells. Br. J. Cancer 84, 936-945.
54. Squadroni, M. and Fazio, N. (2010). Chemotherapy in pancreatic adenocarcinoma. Eur. Rev. Med. Pharmacol. Sci. 14, 386-394.
55. Sternlicht, M. D., Sunnarborg, S. W., Kouros-Mehr, H., Yu, Y., Lee, D. C. and Werb, Z. (2005). Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. Development 132, 3923-3933.
56. Sunnarborg, S. W., Hinkle, C. L., Stevenson, M., Russell, W. E., Raska, C. S., Peschon, J. J., Castner, B. J., Gerhart, M. J., Paxton, R. J., Black, R. A. et al. (2002). Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J. Biol. Chem. 277, 12838-12845.
57. Torregrosa, D., Bolufer, P., Lluch, A., Lopez, J. A., Barragan, E., Ruiz, A., Guillem, V., Munarriz, B. and Garcia Conde, J. (1997). Prognostic significance of c-erbB-2/neu amplification and epidermal growth factor receptor (EGFR) in primary breast cancer and their relation to estradiol receptor (ER) status. Clin. Chim. Acta 262, 99-119.
58. Toyoda, H., Komurasaki, T., Ikeda, Y., Yoshimoto, M. and Morimoto, S. (1995a). Molecular cloning of mouse epiregulin, a novel epidermal growth factor-related protein, expressed in the early stage of development. FEBS Lett. 377, 403-407.
59. Toyoda, H., Komurasaki, T., Uchida, D., Takayama, Y., Isobe, T., Okuyama, T. and Hanada, K. (1995b). Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J. Biol. Chem. 270, 7495-7500.
60. Toyoda, H., Komurasaki, T., Uchida, D. and Morimoto, S. (1997). Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family. Biochem. J. 326, 69-75.
61. Turner, N., Pearson, A., Sharpe, R., Lambros, M., Geyer, F., Lopez-Garcia, M. A., Natrajan, R., Marchio, C., Iorns, E., Mackay, A. et al. (2010). FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer. Cancer Res. 70, 2085-2094.
62. Ugolini, F., Adelaide, J., Charafe-Jauffret, E., Nguyen, C., Jacquemier, J., Jordan, B., Birnbaum, D. and Pebusque, M. J. (1999). Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes. Oncogene 18, 1903-1910.
63. Welm, B. E., Freeman, K. W., Chen, M., Contreras, A., Spencer, D. M. and Rosen, J. M. (2002). Inducible dimerization of FGFR1: development of a mouse model to analyze progressive transformation of the mammary gland. J. Cell Biol. 157, 703-714.
64. Wiesen, J. F., Young, P., Werb, Z. and Cunha, G. R. (1999). Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development. Development 126, 335-344.
65. Xian, W., Schwertfeger, K. L., Vargo-Gogola, T. and Rosen, J. M. (2005). Pleiotropic effects of FGFR1 on cell proliferation, survival, and migration in a 3D mammary epithelial cell model. J. Cell Biol. 171, 663-673.
66. Xian, W., Schwertfeger, K. L. and Rosen, J. M. (2007). Distinct roles of fibroblast growth factor receptor 1 and 2 in regulating cell survival and epithelial-mesenchymal transition. Mol. Endocrinol. 21, 987-1000.
67. Xian, W., Pappas, L., Pandya, D., Selfors, L. M., Derksen, P. W., de Bruin, M., Gray, N. S., Jonkers, J., Rosen, J. M. and Brugge, J. S. (2009). Fibroblast growth factor receptor 1-transformed mammary epithelial cells are dependent on RSK activity for growth and survival. Cancer Res. 69, 2244-2251.
68. Xie, W., Paterson, A. J., Chin, E., Nabell, L. M. and Kudlow, J. E. (1997). Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development. Mol. Endocrinol. 11, 1766-1781.
69. Yuen, T., Zhang, W., Ebersole, B. J. and Sealfon, S. C. (2002). Monitoring G-proteincoupled receptor signaling with DNA microarrays and real-time polymerase chain reaction. Methods Enzymol. 345, 556-569.
70. Zhou, W., Hur, W., McDermott, U., Dutt, A., Xian, W., Ficarro, S. B., Zhang, J., Sharma, S. V., Brugge, J., Meyerson, M. et al. (2010). A structure-guided approach to creating covalent FGFR inhibitors. Chem. Biol. 17, 285-295.
71. Zhu, Z., Kleeff, J., Friess, H., Wang, L., Zimmermann, A., Yarden, Y., Buchler, M. W. and Korc, M. (2000). Epiregulin is up-regulated in pancreatic cancer and stimulates pancreatic cancer cell growth. Biochem. Biophys. Res. Commun. 273, 1019-1024.